Shl Telemedicine LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
SHL Telemedicine reports financial results for 2024, appoints a new CEO, and navigates challenges including a goodwill impairment in its German operations and a voluntary delisting from the Nasdaq.
SHL Telemedicine files an amendment to its 20-F report, addressing disclosure control weaknesses and correcting typographical errors.
SHL Telemedicine files its annual report on Form 20-F, detailing its financial performance and operational activities for the fiscal year ended December 31, 2023.